Literature DB >> 15350147

Human DNA polymerases lambda and beta show different efficiencies of translesion DNA synthesis past abasic sites and alternative mechanisms for frameshift generation.

Giuseppina Blanca1, Giuseppe Villani, Igor Shevelev, Kristijan Ramadan, Silvio Spadari, Ulrich Hübscher, Giovanni Maga.   

Abstract

Human DNA polymerases (pols) beta and lambda could promote template slippage and generate -1 frameshifts on defined heteropolymeric DNA substrates containing a single abasic site. Kinetic data demonstrated that pol lambda was more efficient than pol beta in catalyzing translesion DNA synthesis past an abasic site, particularly in the presence of low nucleotide concentrations. Moreover, pol lambda was found to generate frameshifts in two ways: first, by using a nucleotide-stabilized primer misalignment mechanism, or second, by promoting primer reannealing using microhomology regions between the terminal primer sequence and the template strand. Our results suggest a molecular mechanism for the observed high in vivo rate of frameshifts generation by pol lambda and highlight the remarkable ability of pol lambda to promote microhomology pairing between two DNA strands, further supporting its proposed role in the nonhomologous end joining process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15350147     DOI: 10.1021/bi049050x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

Review 1.  Polymerases in nonhomologous end joining: building a bridge over broken chromosomes.

Authors:  Dale A Ramsden
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

Review 2.  Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance.

Authors:  Lauren S Waters; Brenda K Minesinger; Mary Ellen Wiltrout; Sanjay D'Souza; Rachel V Woodruff; Graham C Walker
Journal:  Microbiol Mol Biol Rev       Date:  2009-03       Impact factor: 11.056

Review 3.  DNA polymerase family X: function, structure, and cellular roles.

Authors:  Jennifer Yamtich; Joann B Sweasy
Journal:  Biochim Biophys Acta       Date:  2009-07-23

4.  In vitro gap-directed translesion DNA synthesis of an abasic site involving human DNA polymerases epsilon, lambda, and beta.

Authors:  Giuseppe Villani; Ulrich Hubscher; Nadege Gironis; Sinikka Parkkinen; Helmut Pospiech; Igor Shevelev; Giulia di Cicco; Enni Markkanen; Juhani E Syväoja; Nicolas Tanguy Le Gac
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

5.  NHEJ and its backup pathways in chromosomal translocations.

Authors:  Michael R Lieber
Journal:  Nat Struct Mol Biol       Date:  2010-04       Impact factor: 15.369

6.  Human base excision repair creates a bias toward -1 frameshift mutations.

Authors:  Derek M Lyons; Patrick J O'Brien
Journal:  J Biol Chem       Date:  2010-06-11       Impact factor: 5.157

Review 7.  Ribonucleotide discrimination by translesion synthesis DNA polymerases.

Authors:  Alexandra Vaisman; Roger Woodgate
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-07-04       Impact factor: 8.250

8.  The block of DNA polymerase delta strand displacement activity by an abasic site can be rescued by the concerted action of DNA polymerase beta and Flap endonuclease 1.

Authors:  Giovanni Maga; Barbara van Loon; Emmanuele Crespan; Giuseppe Villani; Ulrich Hübscher
Journal:  J Biol Chem       Date:  2009-03-27       Impact factor: 5.157

9.  Conferring a template-dependent polymerase activity to terminal deoxynucleotidyltransferase by mutations in the Loop1 region.

Authors:  Félix Romain; Isabelle Barbosa; Jérôme Gouge; François Rougeon; Marc Delarue
Journal:  Nucleic Acids Res       Date:  2009-06-05       Impact factor: 16.971

10.  DNA models of trinucleotide frameshift deletions: the formation of loops and bulges at the primer-template junction.

Authors:  Walter A Baase; Davis Jose; Benjamin C Ponedel; Peter H von Hippel; Neil P Johnson
Journal:  Nucleic Acids Res       Date:  2009-01-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.